- Q1 2024 Kymera Therapeutics Inc Earnings Call TranscriptMay 02, 2024$36.3 (+0.17%)Earnings
- Q4 2023 Kymera Therapeutics Inc Earnings Call TranscriptFeb 22, 2024$40.49 (+4.71%)Earnings
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Kymera Therapeutics Inc Virtual Immunology R&D Day TranscriptJan 04, 2024
- Kymera Therapeutics Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Kymera Therapeutics Inc Earnings Call TranscriptNov 02, 2023$12.08 (+4.59%)Earnings
- Kymera Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Kymera Therapeutics Inc Earnings Call TranscriptAug 03, 2023$23.88 (+11.07%)Earnings
- Kymera Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Kymera Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Kymera Therapeutics Inc Earnings Call TranscriptMay 04, 2023$26.24 (-15.08%)Earnings
- Q4 2022 Kymera Therapeutics Inc Earnings Call TranscriptFeb 23, 2023$33.16 (+5.17%)Earnings
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Kymera Therapeutics Inc Investor Webcast KT-474 Clinical Update Call TranscriptDec 14, 2022
- Kymera Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Kymera Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Kymera Therapeutics Inc Earnings Call TranscriptNov 03, 2022$30.92 (+7.55%)Earnings
- Kymera Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Kymera Therapeutics Inc Earnings Call TranscriptAug 09, 2022$30.35 (-3.44%)Earnings
- Kymera Therapeutics Inc at UBS Global Healthcare Conference TranscriptMay 23, 2022
- Kymera Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Kymera Therapeutics Inc Earnings Call TranscriptMay 03, 2022$24.88 (-23.98%)Earnings
- Kymera Therapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Kymera Therapeutics Inc To Host Virtual R&D Day TranscriptDec 16, 2021
- Kymera Therapeutics Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Kymera Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- Kymera Therapeutics Inc To Discuss Data From KT-474 Phase 1 Trial Call TranscriptOct 27, 2021
- Kymera Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Kymera Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Kymera Therapeutics Inc at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Kymera Therapeutics Inc Presenting at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
Kymera Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. My name is (inaudible). I'm a member of the health care team at JPMorgan. And it's my pleasure today to introduce Nello Mainolfi, the founder, President and Chief Executive Officer of Kymera Therapeutics. As a quick reminder, if you'd like to ask a question, please do so using the Q&A tool at the bottom of your screens. And with that, I'll pass over to you, Nello.
Thanks, (inaudible). Thanks, everyone. Thanks for the opportunity to come here today virtually and present to you, tell you about Kymera. So I'd like to start with maybe Slide 3. And in the course of the presentation, we'll go through a couple of slides with questions. And those questions are questions that have defined the path at Kymera for the past 4, 4.5 years. So the first question around which we really founded the company in 2016 was, what if you could remove disease-causing protein with a small molecule-based technology? And what is, by doing so, you're able to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)